Best of PsA on Day 1
Can computers tell the difference between RA & PsA?
Deucravacitinib in PsA
Differences in Presentation and Outcomes of Early vs Late Onset PsA
Opioids and Health Care Utilization in PsA and AS
Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor
PsA Cycling or Switching MOAs
The Dietary Intervention in PsA (DIPSA) Study
Ultrasound in PsA
Upadacitinib vs Adalimumab in PsA using RAPID3
Giant Cell Arteritis and Polymyalgia Rheumatica Update
JAK Inhibitors for New Indications
Top 3 Messages About JAK Inhibitor Safety
Pain in RA: Different Drugs for Different Mechanisms
JAK Inhibitors for New Indications
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Treat to Target Outcomes in Early AxSpA
Does Telemonitoring in SpA Work?
PsA Treatment: is Earlier Better?
JAK Inhibitors for New Indications
Transition from Psoriasis to PsA: Can we Prevent It?
EULAR 2024 Daily Recap - Days 1 & 2
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Voclosporin and Steroids in Lupus Nephritis
3 Big Lupus Themes from EULAR 2024
Does B Cell Depletion Matter?
Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive